NTC, an international pharmaceutical company headquartered in Milan, Italy, announced today to have embraced a strategic ...

discussed new advancements in ADC technologies, including the role of complex chemistries. Pharmaceutical Technology® Europe spoke with Nicolas Camper, senior director—Bioconjugation Chemistry at ...

High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.

At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...

2024 at CPHI Milan in Milan, Italy (1). And the winners are: The winners were chosen from a previous list of finalists announced on Sept. 6, 2024 (2). The new Future Leader category was awarded to ...

The refined brand highlights Curia’s key capabilities and personalized approach across small molecules, generic APIs and ...

OneSource Specialty Pharma, a newly formed CDMO, is formed from the merger of three CDMO businesses within the Str ...

Being recognized by CPHI with this prestigious award for ... to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise in regulatory sciences ...

We’re excited to participate in CPHI Milan and look forward to forging new partnerships.” OneSource is currently undergoing regulatory approvals and, upon completion, will be listed on the India stock ...

In Monza, Italy, Thermo Fisher is using next-generation technologies, such as augmented reality and virtual reality, in its new Training Center and Aseptic Academy to provide employees with hands ...